(905) 271 2709 mail@focalpointresearch.net
Focal Point
  • Home
  • About
  • Team
  • Services
    • Cosmetic Consultants
    • Natural Health Products
    • Drugs
    • Medical Devices
    • Consumer Products
    • Technology
    • FDA Consulting
    • Health Canada Consultants
    • Regulatory Affairs
    • Pharmacovigilance Services
  • Innovation
  • Articles
  • Contact
Select Page
Extension of Period of Validity for Site Licenses

Extension of Period of Validity for Site Licenses

by Jennifer P | Mar 7, 2021 | Canadian Quality Assurance, Importation of NHPs, Natural Health Products

If you have a Site License set to expire by March 31, 2021, the NNHPD is providing an extension for the site license period of validity until June 01, 2021. This is due to license renewal delays resulting from the COVID-19 pandemic. The extension is applicable to...

Effects of Sterigenics Plant Shutdown on Medical Device Licences (MDL) in Canada

by Jennifer P | May 1, 2019 | Canadian Regulatory, Medical Devices, Research/Science/Technology, U.S. Regulatory

Sterigenics, an international company who provides sterilization solutions for medical devices, pharmaceutical, commercial, and food industries, has shut down its plant in Willowbrook, Illinois. The recent shutdown, which took place in February 2019, was linked to the...

Amway Launches 50 New Apps with New Digital Technology Model

by Jennifer P | Apr 24, 2019 | Cosmetics, OTC Drugs, Research/Science/Technology, U.S. Regulatory

Amway, an American multi-level marketing company that sells health, beauty, and home care products, has approached a new take on improving their business before outsider digital technology disrupts it. They recently teamed up with Texas-based software company, Kony,...

New Self-Care Framework Timeline

by Jennifer P | Apr 17, 2019 | Canadian Regulatory, Cosmetics, Natural Health Products, OTC Drugs

Health Canada is working towards improving the way self-care products (cosmetics, NHPs, and non-prescription drugs) are regulated in Canada. These changes will be implemented via the “Self-Care Framework” to regulate low-risk self care products in the same way, and...

Reclassification of High-Level Disinfectants and Sterilant Solutions as Class II Medical Devices

by Jennifer P | Mar 26, 2019 | Canadian Regulatory, Medical Devices

Health Canada issued a notice on March 18th, 2018 regarding changes to classification of high-level disinfectant and sterilant solutions intended for use on medical devices. Instead of being regulated by the Food and Drug Regulations (FDR), disinfectants and...
« Older Entries

Recent Posts

  • FDA OTC MONOGRAPH DRUG USER FEE RATES FOR FISCAL YEAR 2021
  • Phase I of the Self-Care Framework
  • Changes to INCI Names for Hydrocarbons
  • Health Canada Risk Evaluation of N-nitrosamine Impurities: First Step Deadline Fast Approaching
  • Interim Order No. 2 Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in Relation to COVID-19 (IO No. 2)

Recent Comments

    Archives

    • March 2021
    • February 2021
    • January 2021
    • November 2020
    • October 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018

    Categories

    • Canadian Quality Assurance
    • Canadian Regulatory
    • Cosmetics
    • European Regulatory
    • Events/Company Updates
    • Importation of NHPs
    • Innovation
    • Innovation
    • Medical Devices
    • Natural Health Products
    • OTC Drugs
    • Our View
    • Research/Science/Technology
    • U.S. Regulatory
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Copyright © 2021 Focal Point Research Inc.
    Privacy Policy | Terms of Use
    Website Design and Development by PLAY